Fortis Therapeutics

Fortis Therapeutics is an immuno-oncology biotechnology company dedicated to developing novel antibody-drug conjugate therapies for late-stage multiple myeloma and advanced prostate cancer. Fortis Therapeutics was established based on exclusive licensed technology from UCSF and developed in the laboratory of Dr. Bin Liu, providing innovative solutions to help address business challenges.